Scientist examining a microplate in a pharmaceutical research laboratory

The Home of External Innovations

Where science findsits way forward.

A trusted global network for discovering, presenting and advancing pharmaceutical and academic assets.

Free asset submission. Immediate publication. Continuous policy oversight.

Built forPharma & biotechUniversitiesResearch institutesIndependent laboratoriesTechnology-transfer officesScientific founders

01 / Platform

External innovation, connected

From research record
to partnering conversation.

InOutBio gives credible science a structured route to discovery. Asset owners present the opportunity. Search members find the fit. Owners control visibility while the platform protects contact and engagement.

See how the network works

For researchers, institutions and asset owners

Give your science a credible public identity.

Submit assets without a listing fee, build an official pipeline and choose the opportunity you are ready to pursue.

Unlimited asset submissions
Official references and certificates
Out-licensing and co-development visibility
Owner-only, anonymous reach analytics

Publish your first asset

For licensing, scouting and innovation teams

Discover opportunities with scientific context.

Search public assets, identify the owner and progress a focused expression of interest through controlled access.

Scientific and development-stage search
Entitled owner contact access
Traceable expressions of interest

Start searching

New / Governed access

A two-sided licensing signal

Owners protect supply. Approved search teams declare demand.

InOutBio now separates the two roles at account level. Asset Owners manage only their own portfolio and see what the market is seeking. Asset Search members enter discovery only after administrator approval.

01 / Asset Owner

A private operating lane for your own assets.

Search of other owners' submissions is unavailable. Instead, a dedicated Show Asset Interest view surfaces approved buyer demand without exposing another portfolio.

Immutable roleAdmin approvalPurpose-led access

02 / Asset Search

Turn licensing strategy into a visible brief.

Approved search teams can publish structured, non-confidential criteria across therapeutic area, modality, stage, geography and partnering model for Asset Owners to assess.

Apply for Asset Search access

Built for credible participation.Registration intent cannot be switched at login. Search and licensing-brief publishing activate only after an administrator decision.

A network with standards

Visibility is governed without delay.

01
Structured submission
Scientific, development and opportunity details.
02
Immediate publication
Release at the owner's selected visibility level.
03
Continuous policy oversight
Policy holds, protected contact and accountable action.

02 / Asset portfolio

Your research has a pipeline

Make progress visible. Keep disclosure deliberate.

Organize every asset from discovery to market, publish only the records you choose and share an InOutBio-branded portfolio with collaborators and institutions.

Official portfolio reference Download and LinkedIn sharing Public and protected visibility

Know when your science is being seen.Track aggregate viewers for every public asset and shared portfolio. Viewer identities are never disclosed.

Build My Pipeline

Portfolio ownerDr. Asha Mehta

Portfolio numberIOB-PORT-2026-4C72

Asset / opportunityDiscoveryLead opt.PreclinicalINDPhase IPhase IIPhase IIIMarketed

IOB-IBX-214Precision oncologyOut-licensing

IOB-NEO-007Autoimmune diseaseCo-development

IOB-VEC-003Rare genetic diseaseOut-licensing

Portfolio reach · illustrative184 anonymous viewers

Owner-only insight

03 / Network

Beyond licensing assets

One scientific network. More ways to collaborate.

Laboratories & facilities

Instrumentation, workflows, software and bookable access.

Scientific profiles

Expertise, accomplishments and collaboration interests.

Academic opportunities

Research groups, guides and emerging scientific talent.

Official record verification

Confirm an InOutBio asset or portfolio.

Verify an official reference without exposing confidential scientific or owner information.

04 / Principles

Global in reach. Scientific in character.

Science first: Structured evidence before promotion.
Access with purpose: Contact and interest rights follow approval.
Accountable participation: Identity, review decisions and critical actions recorded.

The next opportunity starts here

Bring your science into the home of external innovation.

Submit an asset Join the network

Contact InOutBio

Start a conversation that can move science forward.

Ask about participation, institutional partnerships, facility access or suggest what the network should build next.

Make progress visible. Keep disclosure deliberate.

Organize every asset from discovery to market, publish only the records you choose and share an InOutBio-branded portfolio with collaborators and institutions.

Official portfolio reference Download and LinkedIn sharing Public and protected visibility

Know when your science is being seen.Track aggregate viewers for every public asset and shared portfolio. Viewer identities are never disclosed.

Build My Pipeline

Where science findsits way forward.

From research recordto partnering conversation.

Give your science a credible public identity.

Discover opportunities with scientific context.

Owners protect supply. Approved search teams declare demand.

A private operating lane for your own assets.

Turn licensing strategy into a visible brief.

Visibility is governed without delay.

Make progress visible. Keep disclosure deliberate.

Confirm an InOutBio asset or portfolio.

Global in reach. Scientific in character.

Bring your science into the home of external innovation.

Start a conversation that can move science forward.

Science moves faster.

Where science findsits way forward.

From research recordto partnering conversation.

Give your science a credible public identity.

Discover opportunities with scientific context.

Owners protect supply. Approved search teams declare demand.

A private operating lane for your own assets.

Turn licensing strategy into a visible brief.

Visibility is governed without delay.

Make progress visible. Keep disclosure deliberate.

Confirm an InOutBio asset or portfolio.

Global in reach. Scientific in character.

Bring your science into the home of external innovation.

Start a conversation that can move science forward.

Science moves faster.

From research record
to partnering conversation.

From research record
to partnering conversation.